Haemoglobin Variants and Plasmodium Falciparum Malaria in Children Under Five Years of Age Living in a High and Seasonal Malaria Transmission Area of Burkina Faso
05/2012
Journal Article
Authors:
Bougouma, E.C.;
Tiono, A.B.;
Ouedraogo, A.;
Soulama, I.;
Diarra, A.;
Yaro, J.B.;
Ouedaogo, E.;
Sanon, S.;
Konate, A.T.;
Nebie, I.;
Watson, N.;
Sanza, M.;
Dube, T.J.;
Sirima, S.B.
Secondary:
Malar J
Volume:
11
Pagination:
154
URL:
http://www.ncbi.nlm.nih.gov/pubmed/22559271
Keywords:
Body Temperature; Burkina Faso/epidemiology; Child; Falciparum/diagnosis; Falciparum/epidemiology; Falciparum/genetics; Genetic Predisposition to Disease; Genotype Hemoglobins; Infant; malaria; Newborn Malaria; Preschool Cross-Sectional Studies
Abstract:
BACKGROUND: Genetic factors play a key role in determining resistance/susceptibility to infectious disease. Susceptibility of the human host to malaria infection has been reported to be influenced by genetic factors, which could be confounders if not taken into account in the assessment of the efficacy of interventions against malaria. This study aimed to assess the relationship between haemoglobin genotypes and malaria in children under five years in a site being characterized for future malaria vaccine trials. METHODS: The study population consisted of 452 children living in four rural villages. Hb genotype was determined at enrolment. Clinical malaria incidence was evaluated over a one-year period using combined active and passive surveillance. Prevalence of infection was evaluated via bi-annual cross-sectional surveys. At each follow-up visit, children received a brief clinical examination and thick and thin blood films were prepared for malaria diagnosis. A clinical malaria was defined as Plasmodium falciparum parasitaemia >2,500 parasites/ul and axillary temperature [greater than or equal to]37.5degreesC or reported fever over the previous 24 hours. RESULTS: Frequencies of Hb genotypes were 73.2% AA; 15.0% AC; 8.2% AS; 2.2% CC; 1.1% CS and 0.2% SS. Prevalence of infection at enrolment ranged from 61.9%-54.1% among AA, AC and AS children. After one year follow-up, clinical malaria incidence (95% CI) (episodes per person-year) was 1.9 (1.7-2.0) in AA, 1.6 (1.4-2.1) in AC, and 1.7 (1.4-2.0) in AS children. AC genotype was associated with lower incidence of clinical malaria relative to AA genotype among children aged 1-2 years [rate ratio (95% CI) 0.66 (0.42-1.05)] and 2-3 years [rate ratio (95% CI) 0.37 (0.18-0.75)]; an association of opposite direction was however apparent among children aged 3-4 years. AS genotype was associated with lower incidence of clinical malaria relative to AA genotype among children aged 2-3 years [rate ratio (95% CI) 0.63 (0.40-1.01)]. CONCLUSIONS: In this cohort of children, AC or AS genotype was associated with lower risk of clinical malaria relative to AA genotype only among children aged one to three years. It would be advisable for clinical studies of malaria in endemic regions to consider haemoglobin gene differences as a potentially important confounder, particularly among younger children.
